Vis enkel innførsel

A health technology assessment of the new drugs for inoperable or metastatic malignant melanoma patients

dc.contributor.authorPike, Eva
dc.contributor.authorTorkilseng, Einar Bjørner
dc.contributor.authorSæterdal, Ingvil von Mehren
dc.contributor.authorJimenez, Enrique
dc.contributor.authorOdgaard-Jensen, Jan
dc.contributor.authorHarboe, Ingrid
dc.contributor.authorKlemp, Marianne
dc.date.accessioned2018-01-21T16:37:50Z
dc.date.available2018-01-21T16:37:50Z
dc.date.created2015-12-16T12:38:48Z
dc.date.issued2015
dc.identifier.isbn978-82-8121-993-9
dc.identifier.urihttp://hdl.handle.net/11250/2478558
dc.language.isoeng
dc.publisherNorwegian Knowledge Centre for the Health Services
dc.titleA health technology assessment of the new drugs for inoperable or metastatic malignant melanoma patients
dc.typeResearch report
dc.description.versionpublishedVersion
dc.source.pagenumber117
dc.identifier.cristin1301608
cristin.unitcode7502,7,2,5
cristin.unitcode7502,0,0,0
cristin.unitnameLegemidler og helseøkonomi
cristin.unitnameFolkehelseinstituttet
cristin.ispublishedtrue
cristin.fulltextoriginal


Tilhørende fil(er)

Thumbnail
Filnavn:
K_Rapport_2015_22_Malignt_mela ...
Størrelse:
1.262Mb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel